# In situ neoplasms

> **Root:** Baseline Disease  

> **Chapter:** Chapter II- Neoplasms  

> **Phenotype:** In situ neoplasms  

> **Code:** `CD2_INSITU`

## 🧪 All Participants  
> Sample size: **212749**  
> Cases: **1312**  
> Controls: **211437**
<img src="/Disease/Figures/ALL/Baseline/CD2_INSITU.png"/>
<CsvTable src="/Disease_Data/ALL/Baseline/LG_CD2_INSITU.csv" label="🔍 View full results" />

## 👨 In Males  
> Sample size: **100754**  
> Cases: **223**  
> Controls: **100531**
<img src="/Disease/Figures/Male/Baseline/CD2_INSITU.png"/>
<CsvTable src="/Disease_Data/Male/Baseline/LG_CD2_INSITU.csv" label="🔍 View full results" />

## 👩 In Females  
> Sample size: **111995**  
> Cases: **1089**  
> Controls: **110906**
<img src="/Disease/Figures/Female/Baseline/CD2_INSITU.png"/>
<CsvTable src="/Disease_Data/Female/Baseline/LG_CD2_INSITU.csv" label="🔍 View full results" />
